Alnylam Pharmaceuticals Inc (ALNY)
258.10
-6.37
(-2.41%)
USD |
NASDAQ |
Nov 14, 16:00
256.21
-1.89
(-0.73%)
After-Hours: 20:00
Alnylam Pharmaceuticals Gross Profit (Annual): 1.518B for Dec. 31, 2023
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.518B |
| December 31, 2022 | 868.60M |
| December 31, 2021 | 704.14M |
| December 31, 2020 | 414.80M |
| December 31, 2019 | 194.69M |
| December 31, 2018 | 73.11M |
| December 31, 2017 | 89.91M |
| December 31, 2016 | 47.16M |
| December 31, 2015 |
| Date | Value |
|---|---|
| December 31, 2014 | |
| December 31, 2013 | |
| December 31, 2012 | |
| December 31, 2011 | |
| December 31, 2010 | |
| December 31, 2009 | 100.53M |
| December 31, 2008 | 96.16M |
| December 31, 2007 | 50.90M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Annual) Range, Past 5 Years
194.69M
Minimum
2019
1.518B
Maximum
2023
740.02M
Average
704.14M
Median
2021
Gross Profit (Annual) Benchmarks
| Pfizer Inc | 33.54B |
| BridgeBio Pharma Inc | 6.857M |
| Biomarin Pharmaceutical Inc | 1.904B |
| Gilead Sciences Inc | 20.62B |
| Regeneron Pharmaceuticals Inc | 11.30B |